Pfizer Achieves Development Milestone and 1 Stock that Has Hit 52-Week Highs

Metropcs Communicati (NYSE:PCS): Deutsche Telekom (DTEGY) confirmed it is in talks with MetroPCS intending to operate its subsidiary T-Mobile USA and MetroPCS within a single company, and Deutsche Telekom is to hold the majority of shares. Deutsche stated, “the talks are at a stage where significant issues have not yet been finalized, contracts have not yet been signed and the conclusion of the transaction is still not certain. The Board of Management and Supervisory Board of Deutsche Telekom have therefore not yet taken the resolutions necessary for such a transaction.” The shares closed at $13.57, up $2.05 or 17.8% on the day. They have traded in a 52-week range of $5.53 to $12.48.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Pfizer (NYSE:PFE): Antares Pharma (ATRS) has made an announcement that its partner Pfizer reached a development milestone concerning its undisclosed Consumer Healthcare product. This development milestone in Antares’ collaboration with Pfizer has begun a $750,000 payment to Antares, and during December of 2011, Antares licensed to Pfizer’s Consumer Healthcare Business Unit one of its drug delivery technologies for the development of an product on an exclusive basis for North America. Pfizer has taken the full cost and responsibility for clinical development, manufacturing ,and commercialization of the product in the licensed territory, including particular non-exclusive territories outside of North America. Antares has gotten an upfront payment, and is to gain development and sales based milestones, along with royalties on net sales for three years after it is launched within the U.S. The shares closed at $25.12, up $0.08 or 0.32% on the day. They have traded in a 52-week range of $17.05 to $25.15.

Don’t Miss: Here’s How Big Corporations Are Quietly Cashing In On Food Stamps.